During the present meta-analysis, a number of factors was observed which could be causing the limitation in developing hypothesis/coming to conclusion regarding using CSF tau and Aβ42 as diagnostic markers in differential diagnosis of AD from dementias due to other causes. Here, MAPT is linked to Alzheimer disease.